Drug treatment of chronic-intermittent abdominal cramping and pain: A multi-national survey on usage and attitudes

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 3, 2010, Pages 472-477

  Mueller Lissner, S ^a   Quigley, E M M ^b   Helfrich, I ^c   Schaefer, E ^c  

^a Park Klinik Weissensee   (Germany)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIDIARRHEAL AGENT; IBUPROFEN; LAXATIVE; NON PRESCRIPTION DRUG; PARACETAMOL; PARGEVERINE; PRESCRIPTION DRUG; PROTON PUMP INHIBITOR; SCOPOLAMINE BUTYL BROMIDE; SPASMOLYTIC AGENT; TRIMEBUTINE; UNCLASSIFIED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADOLESCENT; ADULT; ARGENTINA; ARTICLE; ATTITUDE TO ILLNESS; BELGIUM; BRAZIL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; DRUG USE; FEMALE; GERMANY; HUMAN; INTERVIEW; ITALY; MAJOR CLINICAL STUDY; MALE; MEXICO; PRESCRIPTION; PRIORITY JOURNAL; UNITED KINGDOM; UNITED STATES;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANALGESIA; ANTACIDS; ARGENTINA; BELGIUM; BRAZIL; FEMALE; GERMANY; GREAT BRITAIN; HUMANS; ITALY; MALE; MEXICO; MIDDLE AGED; MUSCLE CRAMP; PARASYMPATHOLYTICS; QUESTIONNAIRES; UNITED STATES; YOUNG ADULT;

EID: 77954322804     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04368.x     Document Type: Article

References (16)

1. Clouse RE, Mayer EA, Aziz Q, et al. Functional abdominal pain syn-drome. Gastroenterology 2006 130:1492 1497.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006 130:1480 1491.
3. Gupta V, Moshiree B, Verne GN. Treatment of pain symptoms in irritable bowel syndrome patients. Drugs Today 2004 40:829 836.
4. Mertz HR. Irritable bowel syndrome. N Engl J Med 2003 349:2136 2146.
5. Quigley EMM, Locke GR, Mueller-Lissner S, et al. Prevalence and management of abdominal cramping and pain: a multi-national survey. Aliment Pharmacol Ther 2006 24:411 420.
6. Andrews EB, Eaton SC, Hollis KA, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005 22:935 942.
7. Faresjo A, Grodzinsky E, Foldevi M, Johansson S, Wallander MA. Patients with irritable bowel syndrome in primary care appear not to be heavy healthcare utilizers. Aliment Pharmacol Ther 2006 23:807 814.
8. Hungin APS, Chang L, Locke GR, Dennis EH, Barghout V. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005 21:1365 1375.
9. Hungin APS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003 17:643 650.
10. van den Heuvel-Janssen HA, Borghouts JA, Muris JW, Koes BW, Bouter LM, Knottnerus JA. Chronic non-specific abdominal complaints in general practice: a prospective study on management, patient health status and course of complaints. BMC Fam Pract 2006 7:12.
11. Jellema P, van der Windt DAWM, Schellevis FG, van der Horst HE. Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009 30:695 706.
12. Faresjo A, Anastasiou F, Lionis C, Johansson S, Wallander MA, Faresjo T. Health-related quality of life of irritable bowel syndrome patients in different cultural settings. Health Qual Life Outcomes 2006 4:21.
13. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms in gastrooesophageal reflux disease. Lancet 1990 335:205 208.
14. Faaij RA, Van Gerven JM, Jolivet-Landreau I, et al. Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn. Aliment Pharmacol Ther 1999 13:1605 1610.
15. Di Palo MT. Rating satisfaction research: is it poor, fair, good, very good, or excellent? Arthritis Care Res 1997 10:422 430.
16. Olden K, DeGarmo RG, Jhingran P, et al. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2002 97:3139 3146.